Insider Transactions in Q4 2022 at Prestige Consumer Healthcare Inc. (PBH)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2022
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
14,780
-41.85%
|
$886,800
$60.76 P/Share
|
|
Dec 06
2022
|
William P'Pool Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,780
+29.51%
|
$443,400
$30.56 P/Share
|
|
Dec 02
2022
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
13,862
-40.3%
|
$873,306
$63.6 P/Share
|
|
Dec 02
2022
|
William P'Pool Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,862
+28.73%
|
$401,998
$29.46 P/Share
|
|
Dec 01
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
7,114
-18.47%
|
$433,954
$61.57 P/Share
|
|
Dec 01
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+23.72%
|
$258,300
$41.44 P/Share
|
|
Nov 18
2022
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
38,793
-14.89%
|
$2,288,787
$59.1 P/Share
|
|
Nov 18
2022
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,793
+12.96%
|
$1,124,997
$29.94 P/Share
|